Chemotherapy (journal)
Chemotherapy (journal)[edit | edit source]
Chemotherapy is a peer-reviewed medical journal that focuses on the field of chemotherapy, which is the treatment of disease by the use of chemical substances, especially the treatment of cancer by cytotoxic and other drugs. The journal publishes original research articles, reviews, and case reports related to the development and application of chemotherapeutic agents.
History[edit | edit source]
The journal was established in 1956 and has since been a prominent publication in the field of medical research related to chemotherapy. It is published by S. Karger AG, a Swiss academic publisher known for its contributions to the medical and scientific community.
Scope[edit | edit source]
The scope of the journal includes, but is not limited to, the following areas:
- Development of new chemotherapeutic agents
- Mechanisms of action of chemotherapeutic drugs
- Clinical trials and studies on chemotherapy
- Drug resistance in chemotherapy
- Pharmacokinetics and pharmacodynamics of chemotherapeutic agents
- Combination therapies involving chemotherapeutic drugs
Editorial Board[edit | edit source]
The journal is managed by an editorial board composed of experts in the field of chemotherapy and related disciplines. The board is responsible for the peer-review process and ensuring the quality and relevance of the published content.
Publication Frequency[edit | edit source]
Chemotherapy is published bimonthly, providing six issues per year. Each issue contains a variety of articles that contribute to the ongoing research and development in the field of chemotherapy.
Access and Availability[edit | edit source]
The journal is available both in print and online. Subscribers can access the journal through the publisher's website, and individual articles can be purchased or accessed through institutional subscriptions.
Related Journals[edit | edit source]
Chemotherapy is part of a broader collection of journals published by S. Karger AG, which includes other titles in the fields of oncology, pharmacology, and medical research.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
